{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:40:31Z","timestamp":1791999631412,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences, Shiraz, Iran","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Vitiligo is caused by partial or complete destruction of melanocytes in the affected skin area and influences the patient\u2019s quality of life. Besides physical involvement, vitiligo patients experience a high level of stress. Depression and Anxiety are common psychiatric disorders in vitiligo patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>This study, as the first study, evaluates hopelessness, anxiety, depression and general health of vitiligo patients in comparison with normal controls in an Iranian population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Hundred patients with vitiligo and hundred healthy controls were examined. General health, depression, hopelessness and anxiety were evaluated based on general health questionnaire. Anxiety, depression and hopelessness levels were analyzed using Chi\u2013Square, and the mean value of general health was evaluated through t-test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results showed that anxiety and hopelessness levels were significantly higher in vitiligo patients than those who are in healthy controls. This significant difference refers to high levels of anxiety and hopelessness among women with vitiligo.<\/jats:p>\n                <jats:p>It was also found that the single patients were more anxious, hopeless and depressive, while the married patients were only more anxious and hopeless than those who are in the control group, respectively.<\/jats:p>\n                <jats:p>General health of patients was significantly worse than in healthy controls. The low level of general health in patients was related to poorer level of general health among women with vitiligo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>It seems that women with vitiligo are more mentally stressed than men with vitiligo. Both singles and married vitiligo patients suffer from anxiety and hopelessness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-020-1278-7","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T17:05:03Z","timestamp":1580749503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-7683","authenticated-orcid":false,"given":"Nasrin","family":"Hamidizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ghanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Handjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"issue":"3","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1590\/abd1806-4841.20142573","volume":"89","author":"RG Tarle","year":"2014","unstructured":"Tarle RG, Nascimento LM, Mira MT, Castro CC. Vitiligo--part 1. An Bras Dermatol. 2014;89(3):461\u201370 Epub 2014\/06\/18. PubMed PMID: 24937821; PubMed Central PMCID: PMC4056705.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","volume":"191","author":"DJ Tobin","year":"2000","unstructured":"Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol. 2000;191(4):407\u201316. https:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D Epub 2000\/08\/05 PubMed PMID: 10918216.","journal-title":"J Pathol"},{"issue":"6","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","volume":"100","author":"IC Le Poole","year":"1993","unstructured":"Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol. 1993;100(6):816\u201322 Epub 1993\/06\/01. PubMed PMID: 7684427.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","volume":"22","author":"NC Laddha","year":"2013","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, et al. Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol. 2013;22(4):245\u201350. https:\/\/doi.org\/10.1111\/exd.12103 Epub 2013\/02\/22. PubMed PMID: 23425123.","journal-title":"Exp Dermatol"},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","volume":"4","author":"NB Silverberg","year":"2015","unstructured":"Silverberg NB. The epidemiology of vitiligo. Curr Derm Rep. 2015;4:36\u201343.","journal-title":"Curr Derm Rep"},{"key":"1278_CR6","first-page":"794","volume-title":"Dermatology in general medicine","author":"DB Mosher","year":"1987","unstructured":"Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Disorders of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. New York: McGraw-Hill Book Co.; 1987. p. 794\u2013876."},{"key":"1278_CR7","unstructured":"Masini C, AD Vitiligo. 4th ed. In: Williams H. Birgby M, Diepgen T. Herxheimer A. Naldi L. Rzany B. editors. Evidence-based dermatology. BMJ Publishing Group. 2003."},{"issue":"8","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","volume":"129","author":"PP Majumder","year":"1993","unstructured":"Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993;129(8):994\u20138 Epub 1993\/08\/01. PubMed PMID: 8352624.","journal-title":"Arch Dermatol"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"CD003263","DOI":"10.1002\/14651858.CD003263.pub3","volume":"1","author":"ME Whitton","year":"2006","unstructured":"Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev. 2006;1:CD003263. https:\/\/doi.org\/10.1002\/14651858.CD003263.pub3 PubMed PMID: 16437451.","journal-title":"Cochrane Database Syst Rev"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470760116","volume-title":"Vitiligo","author":"SK Hahn","year":"2000","unstructured":"Hahn SK, Nordlund JJ. Vitiligo. Oxford: Blackwell Science; 2000. p. 1\u2013306."},{"key":"1278_CR11","doi-asserted-by":"crossref","unstructured":"Braun-Falco O, Plewig G, Wolf HH. Dermatologie und Venerologie, 4. Aufl., Depigmentierungen. Berlin, Heidelberg, New York: Springer; 1996. p. 931ff.","DOI":"10.1007\/978-3-642-86183-3"},{"key":"1278_CR12","volume-title":"Pschyrembel Klinisches W\u00f6rterbuch (259., neu bearbeitete Auflage)","author":"W De Gruyter","year":"2002","unstructured":"De Gruyter W. Pschyrembel Klinisches W\u00f6rterbuch (259., neu bearbeitete Auflage). Berlin: Walter de Gruyter Gmbh & Co. KG; 2002."},{"issue":"1","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","volume":"1","author":"J Porter","year":"1979","unstructured":"Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1(1):73\u20137 Epub 1979\/04\/01. PubMed PMID: 499777.","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"1278_CR14","first-page":"493","volume":"39","author":"J Porter","year":"1987","unstructured":"Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis. 1987;39(6):493\u20134 Epub 1987\/06\/01. PubMed PMID: 3608575.","journal-title":"Cutis."},{"issue":"2 Pt 1","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","volume":"22","author":"JR Porter","year":"1990","unstructured":"Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 1990;22(2 Pt 1):221\u20132 Epub 1990\/02\/01. PubMed PMID: 2312803.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4103\/0378-6323.116737","volume":"79","author":"P Pahwa","year":"2013","unstructured":"Pahwa P, Mehta M, Khaitan BK, Sharma VK, Ramam M. The psychosocial impact of vitiligo in Indian patients. Ind J Derm Venereol Leprology. 2013;79(5):679\u201385. https:\/\/doi.org\/10.4103\/0378-6323.116737 Epub 2013\/08\/27. PubMed PMID: 23974584.","journal-title":"Ind J Derm Venereol Leprology"},{"issue":"1","key":"1278_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01369.x","volume":"20","author":"K Ongenae","year":"2006","unstructured":"Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitiligo. Journal of the European Academy of Dermatology and Venereology : JEADV. 2006;20(1):1\u20138. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01369.x Epub 2006\/01\/13. PubMed PMID: 16405601.","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"key":"1278_CR18","doi-asserted-by":"crossref","unstructured":"Sarkar S, Sarkar T, Sarkar A, Das S. Vitiligo and Psychiatric Morbidity: A Profile from a Vitiligo Clinic of a Rural-based Tertiary Care Center of Eastern India. Ind J Dermatol. 2018;63(4):281\u20134. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6052755\/.","DOI":"10.4103\/ijd.IJD_142_18"},{"key":"1278_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/PRBM.S7072","volume":"3","author":"PD Shenefelt","year":"2010","unstructured":"Shenefelt PD. Psychological interventions in the management of common skin conditions. Psychol Res Behav Manag. 2010;3:51\u201363 Epub 2010\/01\/01. PubMed PMID: 22110329; PubMed Central PMCID: PMC3218765.","journal-title":"Psychol Res Behav Manag"},{"issue":"3","key":"1278_CR20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjd.15199","volume":"177","author":"YC Lai","year":"2017","unstructured":"Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708\u201318. https:\/\/doi.org\/10.1111\/bjd.15199 Epub 2016\/11\/24. PubMed PMID: 27878819.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1278_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/S0033291700021644","volume":"9","author":"DP Goldberg","year":"1979","unstructured":"Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychol Med. 1979;9(1):139\u201345 PubMed PMID: 424481.","journal-title":"Psychol Med"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371 PubMed PMID: 13688369.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1037\/h0037562","volume":"42","author":"AT Beck","year":"1974","unstructured":"Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42(6):861\u20135 PubMed PMID: 4436473.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893\u20137 PubMed PMID: 3204199.","journal-title":"J Consult Clin Psychol"},{"issue":"8","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1346-8138.2001.tb00004.x","volume":"28","author":"SK Mattoo","year":"2001","unstructured":"Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol. 2001;28(8):424\u201332 PubMed PMID: 11560159.","journal-title":"J Dermatol"},{"issue":"6","key":"1278_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","volume":"16","author":"SK Mattoo","year":"2002","unstructured":"Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16(6):573\u20138 PubMed PMID: 12482039.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1278_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2340\/00015555-1037","volume":"91","author":"C Kruger","year":"2011","unstructured":"Kruger C, Smythe JW, Spencer JD, Hasse S, Panske A, Chiuchiarelli G, et al. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Acta Derm Venereol. 2011;91(2):152\u20139. https:\/\/doi.org\/10.2340\/00015555-1037 PubMed PMID: 21240455.","journal-title":"Acta Derm Venereol"},{"issue":"20","key":"1278_CR28","first-page":"381","volume":"4","author":"SMR Taghavi","year":"2002","unstructured":"Taghavi SMR. Validity and reliability of the general health questionnaire (GHQ-28) in college students of Shiraz University. J Psycho. 2002;4(20):381\u201398.","journal-title":"J Psycho"},{"issue":"36","key":"1278_CR29","first-page":"27","volume":"18.2","author":"MA Goudarzi","year":"2002","unstructured":"Goudarzi MA. The study of reliability and validity of Beck hopelessness scale in a group of Shiraz University students. J Soc Sci Hum Shiraz Univ. 2002;18.2(36):27\u201339.","journal-title":"J Soc Sci Hum Shiraz Univ"},{"issue":"5","key":"1278_CR30","first-page":"379","volume":"67","author":"H Kaviani","year":"2009","unstructured":"Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N. Reliability and validity of Anxiety and Depression Hospital Scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J. 2009;67(5):379\u201385.","journal-title":"Tehran Univ Med J"},{"issue":"6","key":"1278_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/ijd.13198","volume":"55","author":"AA Amer","year":"2016","unstructured":"Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608\u201314.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1278_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clindermatol.2017.01.001","volume":"35","author":"F Cupertino","year":"2017","unstructured":"Cupertino F, Niemeyer-Corbellini JP, Ramos ESM. Psychosomatic aspects of vitiligo. Clin Dermatol. 2017;35(3):292\u20137. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.01.001 Epub 2017\/05\/18. PubMed PMID: 28511827.","journal-title":"Clin Dermatol"},{"issue":"6","key":"1278_CR33","first-page":"700","volume":"74","author":"M Dolatshahi","year":"2008","unstructured":"Dolatshahi M, Ghazi P, Feizy V, Hemami MR. Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran. Indian J Dermatol Venereol Leprol. 2008;74(6):700 Epub 2009\/01\/31. PubMed PMID: 19177700.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1278_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-5945-4-8","volume":"4","author":"S Aghaei","year":"2004","unstructured":"Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4:8. https:\/\/doi.org\/10.1186\/1471-5945-4-8 Epub 2004\/08\/06. PubMed PMID: 15294022; PubMed Central PMCID: PMC514558.","journal-title":"BMC Dermatol"},{"issue":"5","key":"1278_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4103\/0378-6323.69097","volume":"76","author":"V Mashayekhi","year":"2010","unstructured":"Mashayekhi V, Javidi Z, Kiafar B, Manteghi AA, Saadatian V, Esmaeili HA, et al. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J Dermatol Venereol Leprol. 2010;76(5):592. https:\/\/doi.org\/10.4103\/0378-6323.69097 Epub 2010\/09\/10. PubMed PMID: 20827019.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1278_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12955-016-0490-y","volume":"14","author":"K Hedayat","year":"2016","unstructured":"Hedayat K, Karbakhsh M, Ghiasi M, Goodarzi A, Fakour Y, Akbari Z, et al. Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo quality of life index (VitiQoL). Health Qual Life Outcomes. 2016;14:86. https:\/\/doi.org\/10.1186\/s12955-016-0490-y Epub 2016\/06\/09. PubMed PMID: 27267598; PubMed Central PMCID: PMC4897932.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"1278_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1550-8579(06)80201-9","volume":"3","author":"L Borimnejad","year":"2006","unstructured":"Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: comparison of male and female muslim patients in Iran. Gender Med. 2006;3(2):124\u201330 Epub 2006\/07\/25. PubMed PMID: 16860271.","journal-title":"Gender Med"},{"issue":"6","key":"1278_CR38","first-page":"327","volume":"11","author":"M Al-Harbi","year":"2013","unstructured":"Al-Harbi M. Prevalence of depression in vitiligo patients. Skinmed. 2013;11(6):327\u201330 Epub 2014\/02\/13. PubMed PMID: 24517036.","journal-title":"Skinmed."},{"key":"1278_CR39","doi-asserted-by":"publisher","unstructured":"Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2017. https:\/\/doi.org\/10.1111\/jdv.14739 Epub 2017\/12\/10. PubMed PMID: 29222958.","DOI":"10.1111\/jdv.14739"},{"issue":"3","key":"1278_CR40","first-page":"19","volume":"19","author":"I Ahmed","year":"2007","unstructured":"Ahmed I, Ahmed S, Nasreen S. Frequency and pattern of psychiatric disorders in patients with vitiligo. J Ayub Med Coll Abbottabad. 2007;19(3):19\u201321 Epub 2008\/05\/01. PubMed PMID: 18444584.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"4","key":"1278_CR41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2230.2010.03965.x","volume":"36","author":"O Bilgic","year":"2011","unstructured":"Bilgic O, Bilgic A, Akis HK, Eskioglu F, Kilic EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2011;36(4):360\u20135. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03965.x Epub 2011\/01\/05. PubMed PMID: 21198786.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"1278_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","volume":"152","author":"K Ongenae","year":"2005","unstructured":"Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152(6):1165\u201372.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1278_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000448656","volume":"232","author":"J Catucci Boza","year":"2016","unstructured":"Catucci Boza J, Giongo N, Machado P, Horn R, Fabbrin A, Cestari T. Quality of life impairment in children and adults with Vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments. Dermatology. 2016;232(5):619\u201325.","journal-title":"Dermatology."},{"issue":"3","key":"1278_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/0092623X.2015.1010678","volume":"42","author":"D Sarhan","year":"2016","unstructured":"Sarhan D, Mohammed GF, Gomaa AH, Eyada MM. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with Vitiligo with and without genital affection. J Sex Marital Therapy. 2016;42(3):267\u201376.","journal-title":"J Sex Marital Therapy"},{"issue":"2","key":"1278_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.det.2016.11.002","volume":"35","author":"N Elbuluk","year":"2017","unstructured":"Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in Vitiligo patients. Dermatol Clin. 2017;35(2):117\u201328. https:\/\/doi.org\/10.1016\/j.det.2016.11.002 Epub 2017\/03\/21. PubMed PMID: 28317521.","journal-title":"Dermatol Clin"},{"issue":"2","key":"1278_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","volume":"159","author":"F Sampogna","year":"2008","unstructured":"Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159(2):351\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08678.x Epub 2008\/06\/21. PubMed PMID: 18565189.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1278_CR47","first-page":"163","volume":"73","author":"M Silvan","year":"2004","unstructured":"Silvan M. The psychological aspects of vitiligo. Cutis. 2004;73(3):163\u20137 Epub 2004\/04\/13. PubMed PMID: 15074343.","journal-title":"Cutis."},{"issue":"Pt 3","key":"1278_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1348\/000711299160077","volume":"72","author":"L Papadopoulos","year":"1999","unstructured":"Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Brit J Med Psychol. 1999;72(Pt 3):385\u201396 Epub 1999\/10\/19. PubMed PMID: 10524722.","journal-title":"Brit J Med Psychol"},{"issue":"12","key":"1278_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2165\/00128071-200304120-00003","volume":"4","author":"MA Gupta","year":"2003","unstructured":"Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4(12):833\u201342.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1278_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2133.2003.05097_9.x","volume":"148","author":"D Parsad","year":"2003","unstructured":"Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology life quality index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148(2):373\u20134 Epub 2003\/02\/18. PubMed PMID: 12588405.","journal-title":"Br J Dermatol"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-1278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-020-1278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-1278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T01:31:38Z","timestamp":1612229498000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-020-1278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s12955-020-1278-7","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local Ethics Committee of Shiraz University of Medical Science (EC-SUMS Number: 93\u20136410), Informed consent was obtained from each participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors understand that the manuscript will be freely available on the internet and may be seen by the general public","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}